The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ivosidenib Drugs Market Research Report 2025
Synopsis
Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
The global Ivosidenib Drugs market was valued at US$ 175.3 million in 2023 and is anticipated to reach US$ 238.5 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
Ivosidenib's market driver is its efficacy in treating relapsed or refractory acute myeloid leukemia (AML) with IDH1 mutations. It inhibits the mutated IDH1 enzyme, leading to remission. The niche target population and limited treatment options contribute to its growth. However, challenges include potential side effects, the need for genetic testing to identify eligible patients, and competition from other AML therapies. Despite challenges, Ivosidenib's promising results and ongoing research in AML with IDH1 mutations present opportunities for market expansion.
This report aims to provide a comprehensive presentation of the global market for Ivosidenib Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ivosidenib Drugs.
Report Scope
The Ivosidenib Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ivosidenib Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ivosidenib Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Servier Pharmaceuticals
Segment by Type
60 Tablets
30 Tablets
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ivosidenib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ivosidenib Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
The global Ivosidenib Drugs market was valued at US$ 175.3 million in 2023 and is anticipated to reach US$ 238.5 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
Ivosidenib's market driver is its efficacy in treating relapsed or refractory acute myeloid leukemia (AML) with IDH1 mutations. It inhibits the mutated IDH1 enzyme, leading to remission. The niche target population and limited treatment options contribute to its growth. However, challenges include potential side effects, the need for genetic testing to identify eligible patients, and competition from other AML therapies. Despite challenges, Ivosidenib's promising results and ongoing research in AML with IDH1 mutations present opportunities for market expansion.
This report aims to provide a comprehensive presentation of the global market for Ivosidenib Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ivosidenib Drugs.
Report Scope
The Ivosidenib Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ivosidenib Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ivosidenib Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Servier Pharmaceuticals
Segment by Type
60 Tablets
30 Tablets
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ivosidenib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ivosidenib Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Ivosidenib Drugs Market Overview
1.1 Product Overview and Scope of Ivosidenib Drugs
1.2 Ivosidenib Drugs Segment by Type
1.2.1 Global Ivosidenib Drugs Market Value Comparison by Type (2024-2030)
1.2.2 60 Tablets
1.2.3 30 Tablets
1.3 Ivosidenib Drugs Segment by Application
1.3.1 Global Ivosidenib Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Ivosidenib Drugs Market Size Estimates and Forecasts
1.4.1 Global Ivosidenib Drugs Revenue 2019-2030
1.4.2 Global Ivosidenib Drugs Sales 2019-2030
1.4.3 Global Ivosidenib Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ivosidenib Drugs Market Competition by Manufacturers
2.1 Global Ivosidenib Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ivosidenib Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ivosidenib Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Ivosidenib Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ivosidenib Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ivosidenib Drugs, Product Type & Application
2.7 Ivosidenib Drugs Market Competitive Situation and Trends
2.7.1 Ivosidenib Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ivosidenib Drugs Players Market Share by Revenue
2.7.3 Global Ivosidenib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ivosidenib Drugs Retrospective Market Scenario by Region
3.1 Global Ivosidenib Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ivosidenib Drugs Global Ivosidenib Drugs Sales by Region: 2019-2030
3.2.1 Global Ivosidenib Drugs Sales by Region: 2019-2024
3.2.2 Global Ivosidenib Drugs Sales by Region: 2025-2030
3.3 Global Ivosidenib Drugs Global Ivosidenib Drugs Revenue by Region: 2019-2030
3.3.1 Global Ivosidenib Drugs Revenue by Region: 2019-2024
3.3.2 Global Ivosidenib Drugs Revenue by Region: 2025-2030
3.4 North America Ivosidenib Drugs Market Facts & Figures by Country
3.4.1 North America Ivosidenib Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ivosidenib Drugs Sales by Country (2019-2030)
3.4.3 North America Ivosidenib Drugs Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Ivosidenib Drugs Market Facts & Figures by Country
3.5.1 Europe Ivosidenib Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ivosidenib Drugs Sales by Country (2019-2030)
3.5.3 Europe Ivosidenib Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ivosidenib Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Ivosidenib Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ivosidenib Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Ivosidenib Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Ivosidenib Drugs Market Facts & Figures by Country
3.7.1 Latin America Ivosidenib Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ivosidenib Drugs Sales by Country (2019-2030)
3.7.3 Latin America Ivosidenib Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ivosidenib Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Ivosidenib Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ivosidenib Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ivosidenib Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ivosidenib Drugs Sales by Type (2019-2030)
4.1.1 Global Ivosidenib Drugs Sales by Type (2019-2024)
4.1.2 Global Ivosidenib Drugs Sales by Type (2025-2030)
4.1.3 Global Ivosidenib Drugs Sales Market Share by Type (2019-2030)
4.2 Global Ivosidenib Drugs Revenue by Type (2019-2030)
4.2.1 Global Ivosidenib Drugs Revenue by Type (2019-2024)
4.2.2 Global Ivosidenib Drugs Revenue by Type (2025-2030)
4.2.3 Global Ivosidenib Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Ivosidenib Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ivosidenib Drugs Sales by Application (2019-2030)
5.1.1 Global Ivosidenib Drugs Sales by Application (2019-2024)
5.1.2 Global Ivosidenib Drugs Sales by Application (2025-2030)
5.1.3 Global Ivosidenib Drugs Sales Market Share by Application (2019-2030)
5.2 Global Ivosidenib Drugs Revenue by Application (2019-2030)
5.2.1 Global Ivosidenib Drugs Revenue by Application (2019-2024)
5.2.2 Global Ivosidenib Drugs Revenue by Application (2025-2030)
5.2.3 Global Ivosidenib Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Ivosidenib Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Servier Pharmaceuticals
6.1.1 Servier Pharmaceuticals Corporation Information
6.1.2 Servier Pharmaceuticals Description and Business Overview
6.1.3 Servier Pharmaceuticals Ivosidenib Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Servier Pharmaceuticals Ivosidenib Drugs Product Portfolio
6.1.5 Servier Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ivosidenib Drugs Industry Chain Analysis
7.2 Ivosidenib Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ivosidenib Drugs Production Mode & Process
7.4 Ivosidenib Drugs Sales and Marketing
7.4.1 Ivosidenib Drugs Sales Channels
7.4.2 Ivosidenib Drugs Distributors
7.5 Ivosidenib Drugs Customers
8 Ivosidenib Drugs Market Dynamics
8.1 Ivosidenib Drugs Industry Trends
8.2 Ivosidenib Drugs Market Drivers
8.3 Ivosidenib Drugs Market Challenges
8.4 Ivosidenib Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
